https://www.sciencedirect.com/science/article/pii/S1201971220305348
In the present study, multivariate analysis performed using Cox regression modeling and propensity score matching to control for potential confounders affirmed that treatment with hydroxychloroquine alone and hydroxychloroquine in combination with azithromycin was associated with higher survival among patients with COVID-19. Patients that received neither medication or azithromycin alone had the highest cumulative hazard. The benefits of hydroxychloroquine in our cohort as compared to previous studies maybe related to its use early in the disease course with standardized, and safe dosing, inclusion criteria, comorbidities, or larger cohort. The postulated pathophysiology of COVID-19 of the initial viral infection phase followed by the hyperimmune response suggest potential benefit of early administration of hydroxychloroquine for its antiviral and antithrombotic properties. Later therapy in patients that have already experienced hyperimmune response or critical illness is less likely to be of benefit.
Look here: https://speakwithanmd.com/intake/americasfrontlinedoctors/www.speakwithanmd.com
OK. What are the actual dosages of Hydroxychloroquine, Azithromycin, and Zinc that make up the cure?
You need a doc to determine the prescription meds. The zinc is here:
Zelenko Covid-19 Prophylaxis Protocol Website: Vladimirzelenkomd.com
Prophylaxis is an action taken to prevent or protect against a specified disease. Greek in origin, from the word "phylax", meaning "to guard" and "watching."
Low Risk Patients Young healthy people do not need prophylaxis against Covid 19. In young and healthy people, this infection causes mild cold-like symptoms. It is advantageous for these patients to be exposed to Covid-19, build up their antibodies and have their immune system clear the virus. This will facilitate the development of herd immunity and help prevent future Covid-19 pandemics. However, if these patients desire prophylaxis against Covid-19, then they should take the protocol noted below.
Moderate Risk Patients Patients from this category are healthy but have high potential viral-load exposure. This group includes medical personnel, caregivers of high-risk patients, people who use public transportation, first responders and other essential personnel who are crucial to the continued functioning of society. These patients should be encouraged to take prophylaxis against Covid-19 in accordance with the protocol noted below.
High Risk Patients Patients are considered high risk if they are over the age of 45, or if they are younger than 45 but they have comorbidities, that is, they have other health conditions that put them at risk. These patients have between a 5 to 10% mortality rate if they are infected with Covid-19. These patients should be strongly encouraged to take prophylaxis against Covid-19 in accordance with the protocol noted below.
Protocol for Low and Moderate Risk Patients: Elemental Zinc 25mg 1 time a day1 Vitamin D 5000iu 1 time a day Vitamin C 1000mg 1 time a day2 Quercetin 500mg 1 time a day until a safe and efficacious vaccine becomes available If Quercetin is unavailable, then use Epigallocatechin-gallate (EGCG) 400mg 1 time a day3
Protocol for High Risk Patients: Elemental Zinc 25mg once a day Vitamin D 5000iu 1 time a day Hydroxychloroquine (HCQ4) 200mg 1 time a day for 5 days, then 1 time a week until a safe and efficacious vaccine becomes available If HCQ is unavailable, then use the Protocol for Low and Moderate Risk Patients. 1 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365891/ 2 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318306/ 3 https://pubs.acs.org/doi/10.1021/jf5014633 4 https://www.preprints.org/manuscript/202007.0025/v1 BH
Bookmark thanks